Open AccessThe real-life efficacy and safety of secukinumab therapy (150 and 300 mg) in patients with moderate-to-severe plaque psoriasis: A twelve week, single center, retrospective study
Author(s) -
İncilay Kalay Yıldızhan,
Merve Aygün,
Nihal Kundakçı
Publication year - 2021
Publication title -
deri hastalıkları ve frengi arşivi
Language(s) - English
Resource type - Journals
ISSN - 1019-214X
DOI - 10.4274/turkderm.galenos.2021.70446
Subject(s) - secukinumab , medicine , single center , plaque psoriasis , psoriasis , dermatology , retrospective cohort study , psoriatic arthritis